TCL Archive In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches February 3, 1989
TCL Archive CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years April 16, 1999
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies November 6, 1987